Most recent by Hilary Longhurst, MA, MB BS, FRCP, PhD, FRCPath
SPONSORED CONTENT
March 16, 2023
3 min read
Save
On-demand sebetralstat treatment reduces hereditary angioedema attack symptoms, severity
SAN ANTONIO — Sebetralstat significantly reduced cumulative hereditary angioedema attack and symptom severity compared with placebo, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.
SPONSORED CONTENT
February 07, 2023
1 min read
Save
FDA approves expanded use of Takhzyro for children with hereditary angioedema
The FDA has approved a supplemental biologics license application to expand the use of lanadelumab-flyo for prophylaxis of hereditary angioedema attacks in children aged 2 to younger than 12 years, according to a press release.